Global Landscape of Antibody-Drug Conjugate Clinical Trials for Prostate Cancer

A 1.4 MB Excel file mapping the contemporary landscape of antibody-drug conjugate clinical trials for prostatic neoplasms. The dataset, authored by Shuyu Ren and last updated on May 14, 2026, clarifies development patterns and identifies translational opportunities and gaps.

Use Cases

• Analyze global development patterns of ADCs based on the described landscape mapping.
• Identify translational opportunities and gaps in ADC development for prostate cancer based on the study's stated aim.
• Compare clinical trial characteristics across different targets and payload classes mentioned in the description.

Strengths

• File size is 1.4 MB, indicating a manageable dataset for analysis.
• Released under a CC-BY-4.0 license, allowing for flexible reuse and sharing.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Description metadata is limited; actual data quality requires manual inspection after download.

Provenance

Source

figshare

Freshness

Last updated 2026-05-14 04:30:10; freshness should be verified.

Geography

global